These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


238 related items for PubMed ID: 4949817

  • 1. The neuroleptics. 8. Clinical methodology.
    Ban TA, Bordeleau JM, Debray HR, Hamilton M, Ito H, Overall JE, Pichot P, Reda G, Tetreault L, Volmat R, Wiart C.
    Mod Probl Pharmacopsychiatry; 1970; 5():133-40. PubMed ID: 4949817
    [No Abstract] [Full Text] [Related]

  • 2. Methodology for the clinical investigation of psychotherapeutic drugs.
    Hollister LE, Overall JE.
    J New Drugs; 1965; 5(5):286-93. PubMed ID: 5329632
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical possibility of therapeutic evaluation in pharmacotherapy: efficacy test of a new long-acting neuroleptic, "Pimozide"].
    König L, Lange E, Mucha H, Winkler J, Kunath B.
    Psychiatr Neurol Med Psychol (Leipz); 1971 Jun; 23(6):359-67. PubMed ID: 4940647
    [No Abstract] [Full Text] [Related]

  • 4. [Research on pharmacodynamic reinforcement of neuroleptics by the 1035 M.D].
    Sizaret P, Anglade P, Simon JP.
    Encephale; 1970 Jun; 59(3):278-88. PubMed ID: 5496123
    [No Abstract] [Full Text] [Related]

  • 5. The neuroleptics. 10. Therapeutic problems.
    Barahona-Fernandes HJ, Cazzullo CL, Cocchi A, Denber HC, Freyhan FA, Klerman GL, Köknel O, Levine J, Saarma J, Sarteschi P, Vinar O, Wittenborn JR.
    Mod Probl Pharmacopsychiatry; 1970 Jun; 5():148-56. PubMed ID: 4949818
    [No Abstract] [Full Text] [Related]

  • 6. [Longitudinal profiles of the effects of psychotropic drugs from clinico-methodological viewpoint].
    Helmchen H, Müller-Oerlinghausen B.
    Arzneimittelforschung; 1974 Jul; 24(7):976-80. PubMed ID: 4603668
    [No Abstract] [Full Text] [Related]

  • 7. Personality and the results of psychotropic drug treatment.
    Boleloucký Z, Vinar O, Tosovský J.
    Act Nerv Super (Praha); 1972 Aug; 14(3):183-4. PubMed ID: 5052820
    [No Abstract] [Full Text] [Related]

  • 8. Psychotropic medication with children: an evaluation of procedural biases in results of reported studies.
    Sulzbacher SI.
    Pediatrics; 1973 Mar; 51(3):513-7. PubMed ID: 4575105
    [No Abstract] [Full Text] [Related]

  • 9. The prediction of placebo effect in functional psychoses.
    Vinarová E, Vinar O.
    Act Nerv Super (Praha); 1973 Mar; 15(1):53-4. PubMed ID: 4572683
    [No Abstract] [Full Text] [Related]

  • 10. [Some problems posed by double-blind investigation of psychotropic drugs: clinical trial of Nobrium Roche].
    Chistoni GC.
    Schweiz Arch Neurol Neurochir Psychiatr; 1971 Mar; 108(2):309-15. PubMed ID: 4941608
    [No Abstract] [Full Text] [Related]

  • 11. Techniques used to assess the efficacy of psychotropic drugs: a critical review.
    Newmark CS.
    Psychol Rep; 1971 Jun; 28(3):715-23. PubMed ID: 4934574
    [No Abstract] [Full Text] [Related]

  • 12. Piperacetazine (Quide) in the management of behavioral disorders in mildly retarded institutionalized boys.
    Kurland AA, Goldberg JB.
    Curr Ther Res Clin Exp; 1970 Dec; 12(12):798-804. PubMed ID: 4994685
    [No Abstract] [Full Text] [Related]

  • 13. [National and international legislative aspects of the neuropsychopharmacologic experimentation].
    Campailla G.
    Minerva Med; 1972 Nov 14; 63(81):4399-403. PubMed ID: 4565684
    [No Abstract] [Full Text] [Related]

  • 14. [Statistical notes].
    Lennes G.
    Acta Psychiatr Belg; 1970 Nov 14; 70(6):711-5. PubMed ID: 4931260
    [No Abstract] [Full Text] [Related]

  • 15. The use of neuroleptics in the treatment of dementia in old age. A critical analysis with reference to an experiment with a long-acting oral neuroleptic (penfluridol Janssen).
    Cahn LA, Diesfeldt HF.
    Psychiatr Neurol Neurochir; 1973 Nov 14; 76(6):411-20. PubMed ID: 4592700
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical trial of a new neuroplegic drug, Dixyrazine, in a double blind experiment with subsequent serial analysis].
    Bensch K, Rundberg B.
    Psychiatr Neurol Med Psychol (Leipz); 1965 Mar 14; 17(3):96-100. PubMed ID: 5319300
    [No Abstract] [Full Text] [Related]

  • 17. [Problems of quantitative evaluation and statistical analysis in psychopharmacology, Results and prospects in the clinical field].
    Capitanucci P.
    Arch Psicol Neurol Psichiatr; 1971 Mar 14; 32(4):312-22. PubMed ID: 5146163
    [No Abstract] [Full Text] [Related]

  • 18. Tybamate in the treatment of chronic mental patients.
    Fransway RL, Wells ML, Chen CH.
    Curr Ther Res Clin Exp; 1967 Jan 14; 9(1):42-5. PubMed ID: 4963023
    [No Abstract] [Full Text] [Related]

  • 19. The value of worsening rates in psychiatric clinical trials.
    Dull TA, Tuzel IH, White RF.
    Psychosomatics; 1970 Jan 14; 11(1):50-4. PubMed ID: 4908032
    [No Abstract] [Full Text] [Related]

  • 20. Psychotropic drugs as catalysts of scientific research.
    van Praag HM.
    Psychiatr Neurol Neurochir; 1973 Jan 14; 76(3):159-61. PubMed ID: 4725788
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.